Advertisement

International Journal of Hematology

, Volume 75, Issue 1, pp 107–108 | Cite as

Secondary Acute Promyelocytic Leukemia in a Patient With Non-Hodgkin’s Lymphoma Treated With VP-16 and MST-16

  • Takahiro Okamoto
  • Masaya Okada
  • Takeshi Wakae
  • Ako Mori
  • Hiroyuki Takatsuka
  • Eizo Kakishita
Letter to the Editor

Keywords

Psoriasis Acute Myeloid Leukemia Acute Promyelocytic Leukemia Acute Myelogenous Leukemia Pirarubicine 

References

  1. 1.
    Kagami Y, Ariyoshi Y, Horiuchi A, et al. Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin’s lym- phoma with two topoisomerase II inhibitors, MST-16 and VP-16.Int J Hematol. 1996;64:221–229.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Okamoto T, Nishimura Y, Yamada S, et al. Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP- 16, for refractory or relapsed non-Hodgkin’s lymphoma.Acta Haematol. 2000;104:128–130.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lym- phoblastic leukemia.N Engl J Med. 1991;325:1682–1687.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Winick NJ, McKenna RW, Shuster JJ, et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.J Clin Oncol. 1993;11:209–217.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Caffrey EA, Daker MG, Horton JJ. Acute myeloid leukaemia after treatment with razoxane.Br J Dermatol. 1985;113:131–134.CrossRefPubMedGoogle Scholar
  6. 6.
    Xue Y, Lu D, Guo Y, Lin B. Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis.Leukemia Res. 1992;16:1113–1123.CrossRefGoogle Scholar
  7. 7.
    Rubnitz JE, Camitta BM, Mahmoud H, et al. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19) (q23;p13.3) translocation.J Clin Oncol. 1999;17:191–196.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Mitterbauer G, Zimmer C, Fonatsch C, et al. Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR.Leukemia. 1999;13:1519–1524.CrossRefPubMedGoogle Scholar
  9. 9.
    Andersen MK, Johansson B, Larsen SO, Pedersen-Bjergaard J. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.Haematologia. 1998;83:483–488.Google Scholar

Copyright information

© The Japanese Society of Hematology 2002

Authors and Affiliations

  • Takahiro Okamoto
    • 1
  • Masaya Okada
    • 1
  • Takeshi Wakae
    • 1
  • Ako Mori
    • 1
  • Hiroyuki Takatsuka
    • 1
  • Eizo Kakishita
    • 1
  1. 1.Division of Hematology and Oncology, Department of Internal MedicineHyogo College of MedicineHyogoJapan

Personalised recommendations